Waterton, John Charles http://orcid.org/0000-0002-7734-2290
Funding for this research was provided by:
Innovative Medicines Initiatives 2 Joint Undertaking (116106 (IB4SD-TRISTAN))
Article History
Received: 20 January 2021
Revised: 5 April 2021
Accepted: 27 April 2021
First Online: 12 May 2021
Declarations
:
: John Waterton holds stock in Quantitative Imaging Ltd and is a Director of, and has received compensation from, Bioxydyn Ltd, a for-profit company engaged in the discovery and development of MR biomarkers and the provision of imaging biomarker services.
: Not applicable, as this is a survey of previously published research.
: Not applicable, as this is a survey of previously published research.